Description

Ikra 100 Tablet contains Venetoclax 100 mg, a targeted anti-cancer medicine used to treat certain types of blood cancers. It belongs to the BCL-2 inhibitor class of medications and works by blocking the BCL-2 protein, which helps cancer cells survive. By inhibiting this protein, Venetoclax promotes the natural death of cancer cells, helping slow disease progression and improve treatment outcomes. It is prescribed by oncology specialists and is often used alone or in combination with other anti-cancer medicines. Key Benefits Targeted therapy for specific blood cancers Helps trigger the natural death of cancer cells May improve treatment response when used with other therapies Oral tablet for convenient once-daily administration Designed to provide effective long-term disease management under medical supervision Uses of Ikra 100 Tablet Ikra 100 (Venetoclax) is prescribed for the treatment of: Chronic Lymphocytic Leukemia (CLL) Small Lymphocytic Lymphoma (SLL) Acute Myeloid Leukemia (AML), usually in combination with other medicines for eligible patients How It Works Venetoclax selectively blocks the BCL-2 (B-cell lymphoma-2) protein, which prevents cancer cells from dying naturally. By inhibiting BCL-2, the medicine restores the body's natural process of eliminating abnormal blood cancer cells while minimizing damage to healthy cells compared with traditional chemotherapy. Directions for Use Take exactly as prescribed by your oncologist. Swallow the tablet whole with water and food. Take it at the same time each day. Do not crush, chew, or split the tablet. Drink plenty of water, especially during the initial dose-escalation period, to reduce the risk of tumor lysis syndrome (TLS). Possible Side Effects Some patients may experience: Nausea or vomiting Diarrhea or constipation Fatigue Low white blood cell count (neutropenia) Anemia Low platelet count Fever or infections Muscle or joint pain Seek immediate medical attention if you develop symptoms of tumor lysis syndrome, severe infection, unusual bleeding, or allergic reactions. Precautions Use only under the supervision of an experienced oncologist. Regular blood tests are required during treatment. Inform your doctor about all medicines, vitamins, and herbal supplements you are taking. Avoid grapefruit, Seville oranges, and starfruit during treatment due to potential drug interactions. Not recommended during pregnancy or breastfeeding unless specifically advised by your physician. Storage Store below 30°C in a cool, dry place away from moisture and direct sunlight. Keep out of the reach of children. Frequently Asked Questions Q1. What is Ikra 100 Tablet used for? It is used to treat certain blood cancers, including Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and Acute Myeloid Leukemia (AML), as prescribed by an oncologist. Q2. How does Venetoclax work? It blocks the BCL-2 protein, allowing cancer cells to undergo natural cell death (apoptosis). Q3. Can Ikra 100 be taken with food? Yes. It should be taken with food and water at the same time each day. Q4. Is Ikra 100 chemotherapy? No. Venetoclax is a targeted cancer therapy, not a traditional chemotherapy medicine. Q5. Is a prescription required? Yes. Ikra 100 is a prescription-only medicine and should only be used under specialist medical supervision.